The DOI matches its Crossref record.
Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimüllerian hormone–stratified, dose–response trial in women undergoing in vitro fertilization/intracytoplasmic sperm injection
Open accessAbstract
OBJECTIVE: To evaluate the dose-response relationship of a novel recombinant human FSH (rhFSH; FE 999049) with respect to ovarian response in patients undergoing IVF/intracytoplasmic sperm injection treatment; and prospectively study the influence of initial antimüllerian hormone (AMH) concentrations. DESIGN: Randomized, controlled, assessor-blinded, AMH-stratified (low: 5.0-14.9 pmol/L [0.7-<2.1 ng/mL]; high: 15.0-44.9 pmol/L [2.1-6.3 ng/mL]) trial. SETTING: Seven infertility centers in four countries. PATIENT(S): Two hundred sixty-five women aged ≤37 years. INTERVENTION(S): Controlled ovarian stimulation with either 5.2, 6.9, 8.6, 10.3, or 12.1 μg of rhFSH, or 11 μg (150 IU) of follitropin alfa in a GnRH antagonist cycle. MAIN OUTCOME MEASURE(S): Number of oocytes retrieved. RESULT(S): The number of oocytes retrieved increased in an rhFSH dose-dependent manner, from 5.2 ± 3.3 oocytes with 5.2 μg/d to 12.2 ± 5.9 with 12.1 μg/d. The slopes of the rhFSH dose-response curves differed significantly between the two AMH strata, demonstrating that a 10% increase in dose resulted in 0.5 (95% confidence interval 0.2-0.7) and 1.0 (95% confidence interval 0.7-1.3) more oocytes in the low and high AMH stratum, respectively. Fertilization rate and blastocyst/oocyte ratio decreased significantly with increasing rhFSH doses in both AMH strata. No linear relationship was observed between rhFSH dose and number of blastocysts overall or by AMH strata. Five cases of ovarian hyperstimulation syndrome were reported for the three highest rhFSH doses and in the high AMH stratum. CONCLUSION(S): Increasing rhFSH doses results in a linear increase in number of oocytes retrieved in an AMH-dependent manner. The availability of blastocysts is less influenced by the rhFSH dose and AMH level. CLINICAL TRIAL REGISTRATION NUMBER: NCT01426386.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Ovarian reserve testing: a user’s guide
Tal, R., & Seifer, D. B. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.02.027 · Cited by 510
(2017) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2017.06.015 · Cited by 399
Drakopoulos, P., Blockeel, C., Stoop, D., Camus, M., de Vos, M., Tournaye, H., & Polyzos, N. P. (2016) · Human Reproduction · doi:10.1093/humrep/dev316 · Cited by 384
Nyboe Andersen, A., Nelson, S. M., Fauser, B. C. J. M., García-Velasco, J. A., Klein, B. M., Arce, J.-C., Tournaye, H., De Sutter, P., Decleer, W., Petracco, A., et al. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.10.033 · Cited by 284
Self-citationSub-optimal responders following controlled ovarian stimulation: an overlooked group?
Polyzos, N. P., & Sunkara, S. K. (2015) · Human Reproduction · doi:10.1093/humrep/dev149 · Cited by 106
Metadata
- Authors
- Arce, J.-C., Nyboe Andersen, A., Fernández-Sánchez, M., Visnova, H., Bosch, E., García-Velasco, J. A., Barri, P., de Sutter, P., Klein, B. M., & Fauser, B. C. J. M.
- Venue
- Fertility and Sterility
- Publisher
- Elsevier BV
- Published
- 2014-12
- Volume
- 102
- Issue
- 6
- Pages
- 1633-1640.e5
- ISSN
- 0015-0282 (ISSN-L)
- OpenAlex
- W1996458430
- Cited by
- 191
- References
- 0
- FWCI
- 15.05
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimüllerian hormone–stratified, dose–response trial in women undergoing in vitro fertilization/intracytoplasmic sperm injection. https://app.cochat.ai/papers/10.1016/j.fertnstert.2014.08.013
- The paper
- Arce, J.-C., Nyboe Andersen, A., Fernández-Sánchez, M., Visnova, H., Bosch, E., García-Velasco, J. A., Barri, P., de Sutter, P., Klein, B. M., & Fauser, B. C. J. M. (2014). Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimüllerian hormone–stratified, dose–response trial in women undergoing in vitro fertilization/intracytoplasmic sperm injection. Fertility and Sterility. https://doi.org/10.1016/j.fertnstert.2014.08.013
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.